Skip to main content

Ocugen, Inc.

For the period ended Dec 31, 2025. Filed Mar 4, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 4, 2026

OCGN$0.97+5.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Signatures

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Ocugen, Inc.
Dated: March 4, 2026/s/ Shankar Musunuri
Shankar Musunuri, Ph.D., MBAChairman, Chief Executive Officer & Co-Founder(Principal Executive Officer)
Dated: March 4, 2026/s/ Ramesh Ramachandran
Ramesh Ramachandran, CPA, MBA, CMAChief Accounting Officer(Principal Financial Officer and Principal Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Shankar MusunuriChairman, Chief Executive Officer & Co-FounderMarch 4, 2026
Shankar Musunuri(Principal Executive Officer)
/s/ Ramesh RamachandranChief Accounting OfficerMarch 4, 2026
Ramesh Ramachandran(Principal Financial Officer and Principal Accounting Officer)
/s/ Junge ZhangDirectorMarch 4, 2026
Junge Zhang
/s/ Uday KompellaDirectorMarch 4, 2026
Uday Kompella
/s/ Kirsten CastilloDirectorMarch 4, 2026
Kirsten Castillo
/s/ Blaise ColemanDirectorMarch 4, 2026
Blaise Coleman
/s/ Satish ChandranDirectorMarch 4, 2026
Satish Chandran
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.